[Amantadine treatment in parkinsonism].
D000284:Administration, Oral; D000547:Amantadine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001007:Anxiety / Q000139:chemically induced; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D012893:Sleep Wake Disorders / Q000139:chemically induced
D000547:Amantadine
Amantadinbehandling ved parkinsonisme.